A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2014
A multicenter, randomized, parallel assignment, double blind, placebo-controlled, safety/efficacy phase II study of two different dosages of subcutaneous F8IL10 in patients with active rheumatoid arthritis receiving MTX.
Epistemonikos ID: a4d58566defeeceaf8ac3cfee63079a1c171efa9
First added on: Mar 23, 2022